Related Experiment Video
Updated: May 11, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
[Comment on the article "Severe coronavirus-2 infection background for cardiovascular complications"]
1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Admisión Continua. Ciudad de México, México.
Insights
COVID-19 survivors may face long-term cardiovascular risks due to virus-induced endothelial dysfunction and coagulation changes. Early detection and intervention are crucial to prevent serious complications like pulmonary hypertension and right heart failure.
Area of Science:
- Cardiology
- Virology
- Pathophysiology
Context:
- Growing evidence suggests persistent cardiovascular complications in individuals post-COVID-19 infection.
- Understanding the mechanisms of cardiac and coagulation alterations is vital for patient management.
Purpose:
- To elucidate the pathophysiological mechanisms linking COVID-19 to long-term cardiovascular sequelae.
- To highlight the importance of identifying cardiac endothelial dysfunction and coagulation abnormalities in COVID-19 survivors.
Summary:
- COVID-19 can induce myocardial inflammation and cardiac endothelial dysfunction, leading to vascular microthrombosis and perpetuating cardiac symptoms.
- These alterations contribute to an increased risk of long-term cardiovascular issues, including pulmonary hypertension and right heart failure.
- Proactive screening for these conditions in follow-up care is recommended.
Impact:
- Facilitates targeted therapeutic strategies for COVID-19-related cardiovascular complications.
- Aims to prevent the progression to severe conditions such as pulmonary hypertension and right heart failure.
- Enhances long-term health outcomes for COVID-19 survivors by addressing potential cardiac risks.
Abstract:
Current information is presented on a phenomenon that occurs in patients who had COVID-19 that could contribute to long-term cardiovascular risk. It deals with the mechanisms underlying cardiovascular and coagulation alterations that perpetuate cardiac symptoms caused by alterations induced by the virus or by myocardial inflammation, such as cardiac endothelial dysfunction, which could cause vascular microthrombosis. The intentional search for this in patients under follow-up becomes relevant since there is specific treatment and long-term complications, such as pulmonary hypertension and right heart failure, could be prevented.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

